In recent years great progress has been noted in all medical care sectors, with the invention of innovative medicines, vaccines, diagnostic methods and operative techniques.

At the same time, the development of Genetics and Artificial Intelligence as well as the increasing use of smart phone apps and wearable devices, have brought about expectations for more radical changes in the healthcare sector.

However, the rapid advancement of new and costly technologies on one hand and population aging on the other, have put serious economic stress on all national health systems, at a time when consumers’ demands regarding the use of new pharmaceuticals and technologies are on a constant rising trend.

Therefore, health systems nowadays are required to modernize medical care, contain expenses and improve the quality and efficiency of services offered to patients.

In Greece the situation is even more stifling, not only because of the recession but also due to chronic problems and distortions which have led to an unregulated system of compensation for medical innovation that lacks any assessment procedures.

Recently, all those involved in the healthcare sector have come to realize that they should start thinking of ways to “achieve more while using less”. To this effect, the 3rd Health Innovation Conference aims at highlighting all prospects and challenges that have emerged in medical care, which are linked to the development of new technologies.

PANEL 1

Research and Innovation in the Health Sector: Trends, Prospects and Hurdles

PANEL 2

Value-based Innovation Compensation in the Health Sector

PANEL 3

Health Technology Assessment in the Pharmaceutical Sector: Committee – Hurdles – Prospects

Basic discussion topics

  • Prospects and challenges related to the development of new health technologies
  • Patients’ access to new technologies
  • Hurdles in the research and innovation sector in Greece

PANEL 1

Research and Innovation in the Health Sector: Trends, Prospects and Hurdles

New technological advancements are bound to bring a revolution in the healthcare sector. Participants at the round table 1 will discuss the results of groundbreaking research programs aiming at significantly improving the quality of medical care.

More specifically, the following topics will be presented:

  • Human organs on chips! Scientists hope that this technology will replace laboratory animals and accelerate the development of new, individualized treatments.
  • Artificial Intelligence: analysis of data from cancer patients is used for the prediction of their symptoms during chemotherapy.
  • Mechanical thrombectomy: a new, innovative technique used in many countries and in Greece, which may save patients who have suffered severe strokes not only from death but also from disability.
  • Use of wearable devices: triage in Emergency Departments with the use of vital signs sensors.

PANEL 2

Value-based Innovation Compensation in the Health Sector

Not just in Greece but all over the world, the landscape has changed dramatically in the last years, as the financing pressures that healthcare systems suffer due to the economic crisis and population aging, constitute great challenges for governments, citizens and companies involved in the health sector.

In Greece the situation is even more stifling, not only because of the recession but also due to chronic problems and distortions which have led to an unregulated system of compensation for medical innovation that lacks any assessment procedures.  Recently, all those involved in the healthcare sector have come to realize that they should start thinking of ways to “achieve more while using less”. To this effect, the 3rd Health Innovation Conference aims at highlighting all prospects and challenges that have emerged in medical care, which are linked to the development of new technologies.

 

The problem is that many new technologies (medicines or materials) are complex, expensive and with unclear benefits to patients. Thus, new and flexible tools are needed for the assessment and compensation of new technologies.

Under this light, participants at the round table 2 will look into new models for the assessment and compensation of new technologies. These models are value-based and have started developing on a global scale. In addition, the first Risk Sharing Agreement in Greece, signed between the Onassis Cardiac Surgery Center and Medtronic, will be presented.

Basic discussion topics

  • New assessment and compensation tools
  • Requirements for optimum use of new compensation methods
  • Best utilization of Big Data

Basic discussion topics

  • New medicines that have been granted marketing authorization and await assessment
  • Which new criteria are applicable in Health Technology Assessment?
  • Challenges, hurdles and prospects related to Health Technology Assessment in Greece
  • Link between Assessment Committee and Negotiations Committee

PANEL 3

Health Technology Assessment in the Pharmaceutical Sector: Committee – Hurdles – Prospects

As mentioned above, the rapid technological progress in the health sector is the source of serious concern for politicians and economists. In an effort to contain costs and distribute their limited resources more rationally, many countries have established Health Technology Assessment bodies.

After years of lagging behind, Greece has finally started to take its first tentative steps towards this direction. The government has already formed a Special Committee in the hope that it will evolve into an independent body, while the party of New Democracy has announced its intention to create a new organization.

The operation of the Committee has exposed existing shortcomings and distortions, which led to delays. At the same time the pressure is on, as the European Medicines Agency (EMA) has approved more than 70 new pharmaceuticals in the last year, making their assessment in Greece a matter of utmost urgency.